Avoro Capital Advisors LLC Travere Therapeutics, Inc. Transaction History

Avoro Capital Advisors LLC

  • $6.65 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$14.11 - $26.4 $17.6 Million - $33 Million
-1,249,000 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$23.37 - $31.77 $12.9 Million - $17.5 Million
-551,500 Reduced 30.63%
1,249,000 $31.2 Million
Q4 2020

Feb 16, 2021
BUY
$19.17 - $27.87 $34.5 Million - $50.2 Million
1,800,500 New
1,800,500 $49.1 Million

Others Institutions Holding TVTX

# of Institutions
194
Shares Held
84.6M
Call Options Held
776K
Put Options Held
900K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.16B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Avoro Capital Advisors LLC Portfolio

Follow Avoro Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email